Despite being the most common vaginal condition,1 BV symptoms are often mistaken for a yeast infection2 JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a ...

Clindamycin is an antibiotic. It works to treat bacterial infections when penicillin is not an option. A doctor may recommend clindamycin for certain respiratory infections, lung infections, blood ...

LAVAL, QC / ACCESSWIRE / January 30, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the U.S. launch of CABTREO™ (clindamycin ...

This combination medication contains an antibiotic and drying agent, prescribed for acne.

Clindamycin is an antibiotic in the lincosamide class, active against gram positive bacteria and anaerobes. It binds to the large subunit (50S) of the bacterial ribosome and inhibits new ...

Details concerning the Clindamycin Phosphate combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

Clindamycin is an antibiotic used to treat certain infections, such as skin infections. More common side effects of clindamycin include itching, mild diarrhea, abdominal (stomach) pain, and nausea and ...

(RTTNews) - India-based Glenmark Pharmaceuticals Inc.'s USA subsidiary, Thursday announced the launch of Clindamycin Phosphate Foam, 1 percent for the treatment of acne. The company added that ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Clindamycin Phosphate Gel USP, 1% (USRLD: Cleocin T Gel, 1%). Clindamycin ...

Clindamycin is an antibiotic doctors prescribe to treat tooth infections, particularly if you’re allergic to penicillin. It’s safe for most people but may cause digestive side effects, and should ...

On Wednesday, September 20, the pharmaceutical company Zydus Lifesciences Ltd. announced that it has attained a critical milestone by receiving final approval from the US Food and Drug Administration ...

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "India Clindamycin Phosphate Market, By Region, Competition, Forecast and Opportunities, 2021-2031F" report has been added to ResearchAndMarkets.com's ...